Onkologie. 2007:1(2):71-72

Imaging of gastrointestinal stromal tumor with 18FDG (fluorodeoxyglucosis) method of positron emission tomography

Izabela Makaiová
Klinika nukleárnej medicíny Lekárskej fakulty UK a Onkologického ústavu sv. Alžbety, Bratislava

Because the basal therapeutic agent Imatinib Mesilate in gastrointestinal stromal tumor (GIST) influences very quickly the transport and metabolism of glucose, positron emission tomography with 18F-fluorodeoxyglucoce (PET/18FDG) is an exellent monitoring tool for the therapy response of this. The condition for quantification of this response is a initial investigation in the beginning of the treatment.

Keywords: positron emission tomography, PET, 18FDG, 18F-fluorodexyglucose, GIST, gastrointestinal stromal tumor, Imatinib mesylate

Published: October 23, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Makaiová I. Imaging of gastrointestinal stromal tumor with 18FDG (fluorodeoxyglucosis) method of positron emission tomography. Onkologie. 2007;1(2):71-72.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Van den Abbeele, Badawi RD. Use of positron emission tomography in Oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs). Eur. J. Cancer, 38 (supl. 5), 2002: 560-565. Go to original source... Go to PubMed...
    2. Stoobants S, Goeminne J, Seegers M. 18FDG-positron emission tomography for the early prediction of response in advanced soft ttissue sarcoma treated with imatinib mesylate (Glivec) Eur. J. Cancer, 39, 2003: 2012-2020. Go to original source... Go to PubMed...
    3. Makaiová I. Klinické indikácie pozitrónovej emisnej tomografie (PET) s 18FDG (fluorodeoxyglukózou) v nádorovej diagnostike. Acta chemo-therapeutica, vol. 12, č. 5, 2003: 41-47.
    4. Kováčová S, Ďurkovský A, Veselý J, Makaiová I, Lehotská V, Banki P, Povinec P. Princípy funkčno-anatomickej fúzie tomografických obrazov. Slovenská rádiológia, roč. 12, č. 1, 2005: 20-22. Go to original source...
    5. Makaiová I. Miesto a prínos PET v onkologickej diagnostike. Onkológia, č. 1, 2006: 29-32.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.